Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy.

about

Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy.

Item

http://www.wikidata.org/entity/Q47145424

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Radiotherapy as an alternative ...... oncandidates for chemotherapy.

@en

Radiotherapy as an alternative ...... oncandidates for chemotherapy.

@nl

type

Item

label

Radiotherapy as an alternative ...... oncandidates for chemotherapy.

@en

Radiotherapy as an alternative ...... oncandidates for chemotherapy.

@nl

prefLabel

Radiotherapy as an alternative ...... oncandidates for chemotherapy.

@en

Radiotherapy as an alternative ...... oncandidates for chemotherapy.

@nl

P1476

Radiotherapy as an alternative ...... oncandidates for chemotherapy.

@en

P2093

Byung-Ock Choi

http://www.w3.org/2001/XMLSchema#string

Jong Hoon Lee

http://www.w3.org/2001/XMLSchema#string

Kyu Hye Choi

http://www.w3.org/2001/XMLSchema#string

Soo Yoon Sung

http://www.w3.org/2001/XMLSchema#string

Yoo-Kang Kwak

http://www.w3.org/2001/XMLSchema#string

Yun Hee Lee

http://www.w3.org/2001/XMLSchema#string

P2860

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome

Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.

The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.

Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis.

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.

Primary CNS lymphoma: a clinician's guide.

Whither whole brain radiotherapy for primary CNS lymphoma?

P304

106858-106865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22427

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29290994

http://www.w3.org/2001/XMLSchema#string

P932

5739779

http://www.w3.org/2001/XMLSchema#string